Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Roche reports Q3 earnings - looks to Tecentriq for future

View:

Post by Noteable on Oct 25, 2022 5:23pm

Roche reports Q3 earnings - looks to Tecentriq for future

Roche's pharma revenues declined in the third quarter, but the Swiss major pharma company is looking towards their immune checkpoint inhibitor Tecentriq in adjuvant settings to boost future revenues.

Consequently, ONCY's pancreatic results from the Goblet Phase 2 clinical study could be what leads Roche's gains involving Teccentriq in combination with ONCY's pelareorep.

We will gain more insight into the positive results of the Goblet panceatic cancer cohort on November 11th at the SITC 2022 - 37th Annual Meeting.

https://www.oncolyticsbiotech.com/press-releases/detail/582/oncolytics-biotech-announces-upcoming-presentations-at

247

Comment

Comment by Noteable on Oct 25, 2022 5:36pm

London, UK and Boston, MA – 18 October 2022: The global pharmaceutical industry is set to see sales grow by an annualised 6% between 2022 and 2028, according to the latest World Preview published by Evaluate Ltd. The annual report, which details the future of the biopharmaceutical sector, forecasts industry revenues of $1.6 Trillion in six years’ time. Mike ...more

166

Comment

Comment by Buckhenry on Oct 25, 2022 6:18pm

noteable gets the prestigious fickle finger award for posting the most stuff that has no bearing on oncy...

147

Comment

Comment by Noteable on Oct 27, 2022 12:48pm

October 26, 2022 - https://www.evaluate.com/vantage/articles/news/trial-results/astra-beats-roche-twice-day

102

Comment

Comment by jimsenior on Oct 31, 2022 10:07am

Added some shares this morning! Bonne chance.

130

Comment

Comment by Noteable on Oct 31, 2022 12:12pm

All I saw on the TSX early this morning was Quebec based Desjardins Securities selling into the bid. I don't know how you "Machiavelli senior" could have been doing any "Bonne chance" buying.

126

Comment

Comment by jimsenior on Oct 31, 2022 12:30pm

Do not know who sold them to me, but I bought 800 shares through TD. Yes this morning. As you know I was undecided, and decided to add. One of your posts on sequencing was influential in my thinking I said Bonne Chance because I am under no illusions that that a share price increase is guaranteed. This is a biotech and given the past performance, one needs to be careful. Any further ...more

142

Comment